![James Oliviero](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Oliviero
Director/Board Member at
NUVECTIS PHARMA, INC.
Net worth: 1 M $ as of 31/05/2026
Profile
Mr. James F.
Oliviero is an Independent Director at Nuvectis Pharma, Inc. He is on the Board of Directors at Nuvectis Pharma, Inc. Mr. Oliviero was previously employed as a President, Chief Executive Officer & Director by Checkpoint Therapeutics, Inc., a Chief Financial Officer & Treasurer by Keryx Biopharmaceuticals, Inc., and a Finance Director by ACCESS Oncology, Inc. He received his undergraduate degree from Goizueta Business School-Emory.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/06/2026 | 122,828 ( 0.46% ) | 1 M $ | 31/05/2026 |
James Oliviero active positions
| Companies | Position | Start |
|---|---|---|
| NUVECTIS PHARMA, INC. | Director/Board Member | 01/07/2021 |
Former positions of James Oliviero
| Companies | Position | End |
|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Chief Executive Officer | 30/05/2025 |
| KERYX BIOPHARMACEUTICALS | Director of Finance/CFO | 01/09/2015 |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Director of Finance/CFO | 01/05/2003 |
Training of James Oliviero
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
36
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Goizueta Business School-Emory
 Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkpoint Therapeutics, Inc.
 Checkpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
- Stock Market
- Insiders
- James Oliviero
